Year: All Releases202020192018201720162015201420132012 March 20, 2020 Mersana Therapeutics to Report Updated Data from the XMT-1536 Phase 1 Dose Escalation Study PDF Version February 28, 2020 Mersana Therapeutics Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business Updates PDF Version February 21, 2020 Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2019 Financial Results and Business Updates PDF Version February 18, 2020 Mersana Therapeutics to Present at Upcoming Investor Conferences PDF Version January 10, 2020 Mersana Therapeutics Announces Pipeline Updates and 2020 Strategic Priorities and Milestones PDF Version January 2, 2020 Mersana Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference PDF Version November 8, 2019 Mersana Therapeutics Presents New Preclinical Data from Immunosynthen Platform at the Society for Immunotherapy of Cancer (SITC) 34th Annual Meeting PDF Version November 6, 2019 Mersana Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Updates PDF Version October 30, 2019 Mersana Therapeutics to Host Conference Call Announcing Third Quarter 2019 Financial Results and Business Updates PDF Version September 27, 2019 Mersana Therapeutics to Present at the 2019 Cantor Global Healthcare Conference PDF Version Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next Last page Last
